{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T17:08:18Z","timestamp":1770484098140,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1208\/s12248-012-9325-x","type":"journal-article","created":{"date-parts":[[2012,2,29]],"date-time":"2012-02-29T11:11:52Z","timestamp":1330513912000},"page":"218-224","source":"Crossref","is-referenced-by-count":10,"title":["Pharmacokinetic Evaluation of Intranasally Administered Vinyl Polymer-Coated Lorazepam Microparticles in Rabbits"],"prefix":"10.1208","volume":"14","author":[{"given":"Yanjun","family":"Zhao","sequence":"first","affiliation":[]},{"given":"Marc B.","family":"Brown","sequence":"additional","affiliation":[]},{"given":"Rajeshree H.","family":"Khengar","sequence":"additional","affiliation":[]},{"given":"Matthew J.","family":"Traynor","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"Barata","sequence":"additional","affiliation":[]},{"given":"Stuart A.","family":"Jones","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,3,1]]},"reference":[{"key":"9325_CR1","unstructured":"Touitou E, Godin B, Duchi S. Compositions for nasal delivery. US Patent Appl. 2009;0047234."},{"key":"9325_CR2","unstructured":"Cartt S, Medeiros D. Nasal administration of benzodiazepines. US Patent Appl. 2008;0279784."},{"key":"9325_CR3","unstructured":"Jamieson G, Des Jardin M, Allphin C. Pharmaceutical compositions of benzodiazepines and method of use thereof. US Patent Appl. 2008;0070904."},{"key":"9325_CR4","unstructured":"Cloyd JC, Siegel RA, Grosberg A, Hou H. Supersaturated benzodiazepine solutions and their delivery. US Patent Appl. 2007;0208011."},{"key":"9325_CR5","unstructured":"Wermeling DP. System and method for intranasal administration of lorazepam. US Patent. 2003;6610271."},{"key":"9325_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2007.03.025","volume":"337","author":"HR Costantino","year":"1999","unstructured":"Costantino HR, Illum L, Brandt G, Johnson PH, Quay SC. Intranasal delivery: physicochemical and therapeutic aspects. Int J Pharm. 1999;337:1\u201324.","journal-title":"Int J Pharm"},{"key":"9325_CR7","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","volume":"87","author":"L Illum","year":"2003","unstructured":"Illum L. Nasal drug delivery\u2014possibilities, problems and solutions. J Control Release. 2003;87:187\u201398.","journal-title":"J Control Release"},{"key":"9325_CR8","first-page":"1187","volume-title":"Clarke\u2019s analysis of drugs and poisons: in pharmaceuticals, body fluids, and postmortem material 3rd ed","author":"AC Moffat","year":"2004","unstructured":"Moffat AC, Osselton MD, Widdop B. Clarke\u2019s analysis of drugs and poisons: in pharmaceuticals, body fluids, and postmortem material 3rd ed. London: Pharmaceutical Press; 2004. p. 1187\u20138."},{"key":"9325_CR9","unstructured":"Wermeling DP. System and method for intranasal administration of lorazepam. US Patent Appl. 2006;0147386."},{"key":"9325_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0378-5173(89)90337-2","volume":"54","author":"SWJ Lau","year":"1989","unstructured":"Lau SWJ, Slattery JT. Absorption of diazepam and lorazepam following intranasal administration. Int J Pharm. 1989;54:171\u20134.","journal-title":"Int J Pharm"},{"key":"9325_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1081\/DDC-100102190","volume":"25","author":"MA Hammad","year":"1999","unstructured":"Hammad MA, Muller BW. Solubility and stability of lorazepam in bile salt\/soya phosphatidylcholine-mixed micelles. Drug Dev Ind Pharm. 1999;25:409\u201317.","journal-title":"Drug Dev Ind Pharm"},{"key":"9325_CR12","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1080\/03639040801926063","volume":"34","author":"M Jug","year":"2008","unstructured":"Jug M, Be\u0107irevi\u0107-La\u0107an M. Development of a cyclodextrin-based nasal delivery system for lorazepam. Drug Dev Ind Pharm. 2008;34:817\u201326.","journal-title":"Drug Dev Ind Pharm"},{"key":"9325_CR13","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1021\/bm9001377","volume":"10","author":"FM Goycoolea","year":"2009","unstructured":"Goycoolea FM, Lollo G, Remunan-Lopez C, Quaglia F, Alonso MJ. Chitosan-alginate blended nanoparticles as carriers for the transmucosal delivery of macromolecules. Biomacromolecules. 2009;10:1736\u201343.","journal-title":"Biomacromolecules"},{"key":"9325_CR14","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1177\/00912700122012779","volume":"41","author":"DP Wermeling","year":"2001","unstructured":"Wermeling DP, Miller JL, Archer SM, Manaligo JM, Rudy AC. Bioavailability and pharmacokinetics of lorazepam after intranasal, intravenous and intramuscualal administration. J Clin Pharm. 2001;41:1225\u201331.","journal-title":"J Clin Pharm"},{"key":"9325_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0169-409X(97)00066-5","volume":"29","author":"MD Donovan","year":"1998","unstructured":"Donovan MD, Huang Y. Large molecule and particulate uptake in the nasal cavity: the effect of size on nasal absorption. Adv Drug Deliv Rev. 1998;29:147\u201355.","journal-title":"Adv Drug Deliv Rev"},{"key":"9325_CR16","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1023\/A:1018908705446","volume":"16","author":"R Fernandez-Urrusuno","year":"1999","unstructured":"Fernandez-Urrusuno R, Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm Res. 1999;16:1576\u201381.","journal-title":"Pharm Res"},{"key":"9325_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ijpharm.2004.09.002","volume":"292","author":"A Vila","year":"2005","unstructured":"Vila A, S\u00e1nchez A, Evora C, Soriano I, McCallion O, Alonso MJ. PLA-PEG particles as nasal protein carriers: the influence of the particle size. Int J Pharm. 2005;292:43\u201352.","journal-title":"Int J Pharm"},{"key":"9325_CR18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/jps.20718","volume":"96","author":"L Illum","year":"2007","unstructured":"Illum L. Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems? J Pharm Sci. 2007;96:473\u201383.","journal-title":"J Pharm Sci"},{"key":"9325_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jconrel.2004.04.026","volume":"98","author":"A Vila","year":"2004","unstructured":"Vila A, Gill H, McCallion O, Alonso MJ. Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. J Control Release. 2004;98:231\u201344.","journal-title":"J Control Release"},{"key":"9325_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ejps.2007.09.008","volume":"33","author":"F Buttini","year":"2008","unstructured":"Buttini F, Soltani A, Colombo P, Marriott C, Jones SA. Multilayer PVA adsorption onto hydrophobic drug substrates to engineer drug-rich microparticles. Eur J Pharm Sci. 2008;33:20\u20138.","journal-title":"Eur J Pharm Sci"},{"key":"9325_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ijpharm.2011.02.053","volume":"410","author":"MJ Traynor","year":"2011","unstructured":"Traynor MJ, Zhao Y, Brown MB, Jones SA. Vinyl polymer-coated lorazepam particles for drug delivery to the airways. Int J Pharm. 2011;410:9\u201316.","journal-title":"Int J Pharm"},{"key":"9325_CR22","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1002\/app.22390","volume":"98","author":"SA Jones","year":"2005","unstructured":"Jones SA, Martin GP, Royall PG, Brown MB. Biocompatible polymer blends: effects of physical processing on the molecular interaction of poly(vinyl alcohol) and poly(vinyl pyrrolidone). J Appl Polym Sci. 2005;98:2290\u20139.","journal-title":"J Appl Polym Sci"},{"key":"9325_CR23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0735-6757(99)90079-7","volume":"17","author":"MD Gottwald","year":"1999","unstructured":"Gottwald MD, Akers LC, Liu PK, Orsulak PJ, Corry MD, Bacchetti P, et al. Prehospital stability of diazepam and lorazepam. Am J Emerg Med. 1999;17:333\u20137.","journal-title":"Am J Emerg Med"},{"key":"9325_CR24","unstructured":"Sweetman SC, editor. Martindale: the complete drug reference. 36th ed. London: Pharmaceutical Press; 2009."},{"key":"9325_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jconrel.2006.03.011","volume":"113","author":"J Wang","year":"2006","unstructured":"Wang J, Tabata Y, Morimoto K. Aminated gelatin microspheres as a nasal delivery system for peptide drugs: evaluation of in vitro release and in vivo insulin absorption in rats. J Control Release. 2006;113:31\u20137.","journal-title":"J Control Release"},{"key":"9325_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2006.07.011","volume":"321","author":"A Dokoumetzidis","year":"2006","unstructured":"Dokoumetzidis A, Macheras P. A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system. Int J Pharm. 2006;321:1\u201311.","journal-title":"Int J Pharm"},{"key":"9325_CR27","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/jps.2600501018","volume":"50","author":"T Higuchi","year":"1961","unstructured":"Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci. 1961;50:874\u20135.","journal-title":"J Pharm Sci"},{"key":"9325_CR28","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1111\/j.1365-2222.2009.03306.x","volume":"39","author":"D Baumann","year":"2009","unstructured":"Baumann D, Bachert C, Hogger P. Dissolution in nasal fluid, retention and anti-inflammatory activity of fluticasone furoate in human nasal tissue ex vivo. Clin Exp Allergy. 2009;39:1540\u201350.","journal-title":"Clin Exp Allergy"},{"key":"9325_CR29","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0378-5173(95)04416-7","volume":"134","author":"F Nakamura","year":"1996","unstructured":"Nakamura F, Ohta R, Machida Y, Nagai T. In vitro and in vivo nasal mucoadhesion of some water-soluble polymers. Int J Pharm. 1996;134:173\u201381.","journal-title":"Int J Pharm"},{"key":"9325_CR30","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/j.1552-4604.1994.tb02043.x","volume":"34","author":"L Bailey","year":"1994","unstructured":"Bailey L, Ward M, Mahmoud NM. Clinical pharmacokinetics of benzodiazepines. J Clin Pharmacol. 1994;34:804\u201311.","journal-title":"J Clin Pharmacol"},{"key":"9325_CR31","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1016\/j.addr.2005.07.009","volume":"57","author":"MI Ugwoke","year":"2005","unstructured":"Ugwoke MI, Agu RU, Verbeke N, Kinget R. Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives. Adv Drug Deliv Rev. 2005;57:1640\u201365.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"9325_CR32","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1021\/bm034028p","volume":"4","author":"MM Patel","year":"2003","unstructured":"Patel MM, Smart JD, Nevell TG, Ewen RJ, Eaton PJ, Tsibouklis J. Mucin\/poly(acrylic acid) interactions: a spectroscopic investigation of mucoadhesion. Biomacromolecules. 2003;4(5):1184\u201390.","journal-title":"Biomacromolecules"},{"key":"9325_CR33","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1023\/A:1015823816776","volume":"8","author":"RJ Herman","year":"1991","unstructured":"Herman RJ, Chaudhary A. In vitro binding of lorazepam and lorazepam glucuronide to cholestyramine, colestipol, and activated charcoal. Pharm Res. 1991;8:538\u201340.","journal-title":"Pharm Res"},{"issue":"7","key":"9325_CR34","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1080\/10611860903055470","volume":"17","author":"AG Mistry","year":"2009","unstructured":"Mistry AG, Sys Zoffmann K, J\u00f8rgen JR, Howard KA, Stolnik S, Illum L. Effect of physicochemical properties on intranasal nanoparticle transit into murine olfactory epithelium. J Drug Target. 2009;17(7):543\u201352.","journal-title":"J Drug Target"},{"key":"9325_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1046\/j.1365-2125.2002.t01-10-01714.x","volume":"55","author":"SJ Visser de","year":"2003","unstructured":"de Visser SJ, van der Post JP, de Waal PP, Cornet F, Cohen AF, van Gerven JM. Biomarkers for the effects of benzodiazepines in healthy volunteers. Br J Clin Pharmacol. 2003;55:39\u201350.","journal-title":"Br J Clin Pharmacol"},{"key":"9325_CR36","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2165\/00002018-200326040-00004","volume":"26","author":"MG Terzano","year":"2003","unstructured":"Terzano MG, Rossi M, Palomba V, Smerieri A, Parrino L. New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon. Drug Saf. 2003;26:261\u201382.","journal-title":"Drug Saf"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-012-9325-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12248-012-9325-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-012-9325-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-012-9325-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T23:47:51Z","timestamp":1559605671000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12248-012-9325-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,1]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["9325"],"URL":"https:\/\/doi.org\/10.1208\/s12248-012-9325-x","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,1]]}}}